May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
First Clinical Evaluation of Selective RPE Laser Treatment (SRT) With 200ns Laser Pulses
Author Affiliations & Notes
  • A. F. Walter
    Dept of Ophthalmology, University of Regensburg, Regensburg, Germany
  • P. Prahs
    Dept of Ophthalmology, University of Regensburg, Regensburg, Germany
  • J. Hillenkamp
    Dept of Ophthalmology, University of Regensburg, Regensburg, Germany
  • R. Brinkmann
    Medical Laser Center, Luebeck, Germany
  • V.-P. Gabel
    Dept of Ophthalmology, University of Regensburg, Regensburg, Germany
  • C. Framme
    Dept of Ophthalmology, University of Regensburg, Regensburg, Germany
  • Footnotes
    Commercial Relationships A.F. Walter, None; P. Prahs, None; J. Hillenkamp, None; R. Brinkmann, None; V. Gabel, None; C. Framme, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5095. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. F. Walter, P. Prahs, J. Hillenkamp, R. Brinkmann, V.-P. Gabel, C. Framme; First Clinical Evaluation of Selective RPE Laser Treatment (SRT) With 200ns Laser Pulses. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5095.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Selective RPE laser treatment (SRT) solely affecting the RPE while sparing of the photoreceptors is usually performed with repetitive laser pulses of 1.7µs duration. It was our purpose to evaluate firstly the principle feasibility of using shorter 200ns laser pulses in patients treatment and to determine the angiographic and ophthalmoscopic damage thresholds.

Methods:: Patients with macular disorders [diabetic maculopathy (DMP), geographic atrophy (GA), drusen maculopathy and central serous chorioretinopathy (CSR)] were treated with a prototype of a SRT laser (Med. Laser Center Luebeck GmbH, Germany: Nd:YLF laser; 527nm; 200ns pulse duration; 30 pulses at 100Hz). In average, 16 to 20 spots with a diameter of 200µm were applied. Test lesions with increasing energy were applied at the lower arcade to determine the angiographic and ophthalmoscopic threshold radiant exposures and then to apply the treatment lesions with radiant exposures in between the therapeutic window of both thresholds guided by online optoacoustic measurements. Postoperatively RPE damage was visualized and confirmed by fluorescein angiographic leakage.

Results:: None of the short repetitive 200ns laser pulses led to retinal hemorrhages or retinal ruptures. All treatment lesions were ophthalmoscopically invisible suggesting intact neurosensory retinal structures. RPE damage could be confirmed by angiographic leakage for the treatment lesions. The angiographic damage threshold was determined to be about 100µJ, the ophthalmoscopic one at least about 200µJ. Thus, damage thresholds were significantly lower at a factor of about 2 instead of treating with 1.7µs (angiographic threshold: about 200µJ) using the same laser prototype for same diseases.

Conclusions:: Selective RPE effects can be achieved using shorter 200ns laser pulses in patients treatment. Applied threshold radiant exposures to reach RPE damage were significantly lower than for 1.7µs laser pulses indicating a reduced heat flow into adjacent tissues during the short laser impact.

Clinical Trial:: www.clinicaltrials.gov NCT00403884

Keywords: laser • retinal pigment epithelium • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×